Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: nestegg who wrote (8038)	12/13/1998 10:19:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

I would expect results to be announced at the meeting, Will they, don't know, but that is what I expect. While some on Yahoo have been able to paint this as somehow evil, I would love to see Cor Therapeutics or Ligand Pharmaceuticals change domicile. Why do I feel that way? Because the idea makes sense. Think about any other smaller company you own that is not yet profitable, has a low fair value of its assets and has the potential to generate revenue outside the U.S. Would you want to see them minimize the tax on such revenue? Or would you want them to continue to have a corporate structure which requires them to pay more? To me it is obvious. That is why I have suggested that those with open minds remove XOMA from the equation and see what they think of the concept when applied to another company. I suggest if they still don't like it, vote NO. But if you find the idea appealing, vote YES.